RecruitingPhase 3NCT06617325
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Sponsor: UCB Biopharma SRL
Kansas City, MO · +62 more sites
Lupus clinical trials in Kansas City, MO
4 recruiting lupus studies with a site in Kansas City, MO.
RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
City of Saint Peters, MO · Creve Coeur, MO · Kansas City, MO · +48 more sites
RecruitingPhase 3NCT07430306
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Sponsor: AstraZeneca
Kansas City, MO · +30 more sites
RecruitingPhase 4NCT07611214
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Sponsor: Aurinia Pharmaceuticals Inc.
Kansas City, MO · +26 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.